Posted: Mon., Feb. 7, 2000

'Toy Story 2' success fuels profits at Pixar

$9.6 mil reported is nine times 1999's quarterly earnings

Fueled by the box office glory of "Toy Story 2," Pixar announced fourth quarter profits of $9.6 million, nine times its earnings of $1.1 million during last year's comparable quarter.

Total revenues for the fiscal period were $24.9 million, up from $3.1 million for the same period last year.

For the entire year, Pixar raked in $49.2 million in profits, shooting up from $7.8 million the previous year. Total-year revenues were $121 million vs. $14.3 million in 1998.

"These annual results -- profits just shy of $50 million on revenues of $121 million -- demonstrate Pixar's earnings potential from our new Disney partnership," Pixar CEO Steve Jobs said. "And we are looking forward to another terrific year with revenues ramping up from 'Toy Story 2.' "

So far, the computer-animated pic has amassed $234 million in the U.S. and Canada; it's the No. 2 all-time domestic animated film, behind "The Lion King." International take of "Toy Story 2" has reached $47 million. U.K. bow is slated for Feb. 11.

Past Pixar releases include 1997's "Toy Story" and 1998's "A Bug's Life."


TALKBACK:

Have an opinion about this article? Be the first to comment




Q What are the top 3 things affecting our industry today?
A. Benisha - scams big time!!!! and i can truly say that i have experienced this becoming apart of a fa... more >


Submit this form
Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.